Urology Annals
About UA | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionLogin 
Urology Annals
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 264   Home Print this page  Email this page Small font size Default font size Increase font size

    Article Cited by others

ORIGINAL ARTICLE

Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin

Alkhateeb Sultan S, Neill Mischel, Bar-Moshe Sas, Rhijn Bas Van, Kakiashvili David M, Fleshner Neil, Jewett Michael, Petein Michel, Schulman Claude, Hanna Sally, Bostrom Peter J, Roumeguere Thierry, Shariat Shahrokh F, Rorive Sandrine, Zlotta Alexandre R

Year : 2011| Volume: 3| Issue : 3 | Page no: 119-126

   This article has been cited by
 
1 Considerations on the use of urine markers in the management of patients with high-grade non–muscle-invasive bladder cancer
Ashish M. Kamat,Antonia Vlahou,John A. Taylor,M´Liss A. Hudson,Beate Pesch,Molly A. Ingersoll,Tilmann Todenhöfer,Bas van Rhijn,Wassim Kassouf,H. Barton Grossman,Thomas Behrens,Ashish Chandra,Peter J. Goebell,Juan Palou,Marta Sanchez-Carbayo,Bernd J. Schmitz-Dräger
Urologic Oncology: Seminars and Original Investigations. 2014;
[Pubmed]  [Google Scholar] [DOI]
2 PMN and anti-tumor immunity-The case of bladder cancer immunotherapy
Brincks, E.L. and Risk, M.C. and Griffith, T.S.
Seminars in Cancer Biology. 2013; 23(3): 183-189
[Pubmed]  [Google Scholar]
3 Who needs numbers more: Patients or doctors?
SÅ‚ojewski, M.
Central European Journal of Urology. 2013; 66(1): 8-9
[Pubmed]  [Google Scholar]
4 Guidelines for diagnosis, treatment, and prevention of clostridium difficile infections
Surawicz, C.M. and Brandt, L.J. and Binion, D.G. and Ananthakrishnan, A.N. and Curry, S.R. and Gilligan, P.H. and McFarland, L.V. and Mellow, M. and Zuckerbraun, B.S.
American Journal of Gastroenterology. 2013; 108(4): 478-498
[Pubmed]  [Google Scholar]
5 PMN and anti-tumor immunity—The case of bladder cancer immunotherapy
Erik L. Brincks,Michael C. Risk,Thomas S. Griffith
Seminars in Cancer Biology. 2013; 23(3): 183
[Pubmed]  [Google Scholar] [DOI]
6 Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
Christina M Surawicz,Lawrence J Brandt,David G Binion,Ashwin N Ananthakrishnan,Scott R Curry,Peter H Gilligan,Lynne V McFarland,Mark Mellow,Brian S Zuckerbraun
The American Journal of Gastroenterology. 2013; 108(4): 478
[Pubmed]  [Google Scholar] [DOI]
7 Biomarkers for bladder cancer aggressiveness
Maria Frantzi,Manousos Makridakis,Antonia Vlahou
Current Opinion in Urology. 2012; 22(5): 390
[Pubmed]  [Google Scholar] [DOI]
8 Expression of MMP-9 and WAVE3 in colorectal cancer and its relationship to clinicopathological features
Yi Zhang,Xiao-Ya Guan,Bin Dong,Min Zhao,Jian-Hui Wu,Xiu-Yun Tian,Chun-Yi Hao
Journal of Cancer Research and Clinical Oncology. 2012; 138(12): 2035
[Pubmed]  [Google Scholar] [DOI]
9 Expression of MMP-9 and WAVE3 in colorectal cancer and its relationship to clinicopathological features
Zhang, Y. and Guan, X.-Y. and Dong, B. and Zhao, M. and Wu, J.-H. and Tian, X.-Y. and Hao, C.-Y.
Journal of Cancer Research and Clinical Oncology. 2012; 138(12): 2035-2044
[Pubmed]  [Google Scholar]
10 Superficial papillary urothelial neoplasms of the bladder (pTa e pT1): Correlation of expression of p53, KI-67 and CK20 with histologic grade, recurrence and tumor progression [Neoplasias uroteliais papilíferas superficiais da bexiga (pTa e pT1): Correlação da expressão do p53, KI-67 E CK20 com grau histológico, recidiva e progressão tumoral]
Ogata, D.C. and Marcondes, C.A.P.R. and Tuon, F.F. and Busato Júnior, W.F.S. and Cavalli, G. and Czeczko, L.E.A.
Revista do Colegio Brasileiro de Cirurgioes. 2012; 39(5): 394-400
[Pubmed]  [Google Scholar]
11 Biomarkers for bladder cancer aggressiveness
Frantzi, M. and Makridakis, M. and Vlahou, A.
Current Opinion in Urology. 2012; 22(5): 390-396
[Pubmed]  [Google Scholar]

 

Read this article